Search results
Anne Wojcicki. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent a decade on Wall Street investing in healthcare and felt ...
Dec 14, 2022 · Working as a Wall Street analyst for more than a decade, Anne Wojcicki became convinced that the U.S. health care system didn't help people stay healthy. She co-founded her genetic-testing company ...
Jun 17, 2021 · Anne Wojcicki, the cofounder and CEO of 23andMe, owns 99.4 million shares of the merged company; with shares trading on the Nasdaq under the ticker “ME” at $13.40 as of 3:00pm EDT Thursday ...
Dec 7, 2021 · Anne Wojcicki, Chief Executive Officer of 23andMe, photographed for Forbes by Aaron Kotowski in June 2019. The cofounder and CEO of 23andMe spoke to Assistant Managing Editor Diane Brady about her ...
Apr 25, 2023 · Anne Wojcicki is the co-founder and CEO of 23andme. Jordan Vonderhaar—Bloomberg/Getty Images. Sequencing the human genome for the first time was an incredible feat. Twenty years ago this week ...
“Anne is a true innovator in so many ways for being one of the first digital health technology pioneers, and for thoughtfully creating a business model based on prevention, rather than treatment after the problem has already manifested itself as a disease,” Makower said, adding that Wojcicki’s talk fit within the broader strategy of the ...
Nov 7, 2023 · CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’. 23andMe always had larger aims than at-home genetics testing. In this in-depth interview, Wojcicki explains the company’s foray into drug R&D. Anne Wojcicki attends a 2019 event at the Wallis Annenberg Center for the Performing Arts in Los Angeles.
